102 results on '"Merger, M."'
Search Results
2. Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12
3. Syndrome VEXAS, une présentation cutanée atypique
4. AGO-OVAR 12: A Randomized Placebo-controlled GCIG/ENGOT-Intergroup Phase III trial of standard frontline chemotherapy +/- Nintedanib for advanced ovarian cancer: ID 416
5. Retroperitoneal gas gangrene after colonoscopic polypectomy without bowel perforation in an otherwise healthy individual: report of a case
6. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
7. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor α in T cell induced mucosal damage in the mouse intestine. (Inflammation and Inflammatory Bowel Disease)
8. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine
9. A rare case of hypalbuminaemic oedema
10. Electronic and geometrical structure of Bicyclo(8.1.0)undec-1(10)-en-5-yn-11-one and related compounds
11. AGO-OVAR 12 : A Randomized Placebo-controlled GCIG/ENGOT-Intergroup Phase III trial of standard frontline chemotherapy plus /- Nintedanib for advanced ovarian cancer
12. Exogram - niveau intermédiaire
13. La Toscane face aux innovations de l'industrie lainière, XVIIIe-XIXe siècle , in M. Merger (dir), Transferts de technologies en Méditerranée, Paris, PUPS, 2005, p. 529-549
14. Unabhängige Analyse der AGO-OVAR 12, einer GCIG/ENGOT-Intergroup Phase III Studie mit Nintedanib in der Firstline Therapie beim Ovarialkarzinom
15. AGO-OVAR 12: Eine randomisierte, Placebo-kontrollierte Phase III-Studie zum Einsatz von Carboplatin und Paclitaxel ± Nintedanib beim fortgeschrittenen Ovarialkarzinom (GCIG/ENGOT-Intergroup-Studie)
16. Phase I Dose-Escalation Study to Determine the Maximum Tolerated Dose (Mtd) of Nintedanib (Bibf 1120) in Combination with Carboplatin/Pegylated Liposomal Doxorubicin (Pld) in Patients (Pts) with Recurrent Ovarian Cancer (Roc)
17. Un contratto regale, da Savoia Carignano a Savoia
18. A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.
19. Les entreprises et leur réseaux: hommes, capitaux, techniques et pouvoirs XIXe-XXe siècles
20. The French iron industry, 1820-1860. The change from charcoal- to mineral-fuel based technology
21. ChemInform Abstract: (n.n)Cyclopropenyliophanes.
22. ChemInform Abstract: Cyclic 2-Ynones from Cyclic Alkynes via Ring Enlargement.
23. ChemInform Abstract: Doubly Bridged Biscyclopropenones, a New Family of Phanes.
24. BIBF 1120
25. Ungewöhnlicher Fall einer disseminierten Sarkoidose mit führender gastrointestinaler Symptomatik
26. Riesenkotsteine bei habitueller Obstipation
27. Discussion on the biologic therapy of inflammatory bowel disease
28. 889P - Phase I Dose-Escalation Study to Determine the Maximum Tolerated Dose (Mtd) of Nintedanib (Bibf 1120) in Combination with Carboplatin/Pegylated Liposomal Doxorubicin (Pld) in Patients (Pts) with Recurrent Ovarian Cancer (Roc)
29. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor in T cell induced mucosal damage in the mouse intestine
30. Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells particularly in the presence of subphysiological glucose concentrations
31. Anti-CD3-induced T cell enteropathy is not dependent on TNF-α mediated pathways
32. ChemInform Abstract: Phanes with Three‐ and Four‐Membered Rings as Building Elements
33. Structure and complexation of [5.5]biscyclopropenyliumphane-bistetrafluoroborate
34. Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine
35. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
36. Note préliminaire à l’étude de la dystrophie ovarienne, son importance et sa fréquence en gynécologie
37. ChemInform Abstract: Doubly Bridged Biscyclopropenones, a New Family of Phanes.
38. ChemInform Abstract: Cyclic 2-Ynones from Cyclic Alkynes via Ring Enlargement.
39. ChemInform Abstract: (n.n)Cyclopropenyliophanes.
40. Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
41. Les dictionnaires scolaires d'Augusto Caricati
42. Alberti di Villanuova et son dictionnaire 'universel' bilingue
43. La Confederazione generale dell'industria italiana e la definizione della piccola- media industria nel secondo dopoguerra (anni 1940- 70)
44. La banca in Italia dall’Unità ad oggi: azienda, agenzia, impresa
45. La contribution belge à la création des réseaux internationaux de communication du XIX siècle
46. The Belgian Contribution to the Creation of the 19th Century International Communication Network
47. Calcinosis in systemic sclerosis.
48. Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.
49. Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
50. Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.